These results suggest that PD-L2 mediates tobacco-induced recruitment of Tregs via the RGMB/NFκB/CCL20 cascade, and targeting this pathway might have therapeutic potentials in NSCLC. This evidence concerns the gene PDCD1LG2 and non-small cell lung carcinoma.